<DOC>
	<DOCNO>NCT01571622</DOCNO>
	<brief_summary>The aim present study examine therapeutic effect whey protein concentrate ( WPC 80 ) adult subject type 2 diabetes . Whey protein administer breakfast effect posprandial glucose , insulin , c-peptide , intact total GIP GLP-1 , DPP-4 plasma level assess .</brief_summary>
	<brief_title>Whey Protein Posprandial Glucose , Insulin GLP-1 , GIP DPP4 Type 2 Diabetes</brief_title>
	<detailed_description>Milk dairy product consumption associate low risk metabolic disorder cardiovascular disease ( 1 ) . A population-based prospective study ( CARDIA ) reveal dairy consumption inversely associate prevalence component insulin resistance syndrome ( IRS ) overweight individual ( 2 ) . Whey account 20 % whole milk protein , casein account rest . Whey protein source bioactive component branch chain amino acid ( BCAAs ) could play role control food intake management glucose metabolism , obesity diabetes ( 1,3,4 ) . Whey protein appear insulinotropic glucose lower property healthy adult ( 6-9 ) , also individual type 2 diabetes ( 10,11 ) . The magnitude postprandial blood glucose reduction follow ingestion whey protein comparable observed pharmaceutical intervention sulfonylurea ( 12 ) nateglinide ( 13 ) . These finding imply important role whey protein management type 2 diabetes ( 10 ) . Whey protein seem induce insulinotropic/β-cell-stimulating glucose lower effect via bioactive peptide generate gastrointestinal digestion BCAAs contain β-lactoglobulin , major whey protein ( 14 ) . These bioactive peptide stimulate release several gut hormone , especially incretins , glucose-dependent insulinotropic polypeptide ( GIP ) glucagon-like peptide-1 ( GLP-1 ) , potentiate insulin secretion β-cells also associate control food intake ( 9 , 15-17 ) . Increased plasma level GIP GLP-1 report follow whey ingestion patient type 2 diabetes ( 10 ) . The stimulatory effect whey protein GLP-1 especially important since show postprandial GLP-1 secretion reduce type 2 diabetes ( 18 ) . The bioactive peptide generate whey protein may also serve endogenous inhibitor dipeptidyl peptidase-4 ( DPP-4 ) proximal gut , prevent incretin ( GIP GLP-1 ) degradation ( 19 , 20 ) . Indeed , recently DPP-4 inhibitor find identify Whey protein ( 21 ) . All may reduce postprandial blood glucose level . Incretin action enhance whey protein ingestion , possibly incretin degradation via inhibition DPP-4 ( 19,20 ) . This important light several incretin-based therapy continuous administration GLP-1 ( 19 ) , treatment degradation-resistant GLP-1R agonist ( Exendin-4 ) ( 15,23-25 ) , therapy DPP-4 inhibitor ( Sitagliptin , Liraglutide others gliptines ) ( 15,23-27 ) lead substantial improvement glucose control β-cell function subject type 2 diabetes . Whey protein stimulate GLP-1 secretion prevents inactivation DPP 4 . Thus , potentiate GLP-1 secretion enhance action , ( 15 ) , whey protein may represent valuable tool treat type 2 diabetes .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Type 2 diabetic patient 2 . Duration diabetes : 110 year 3 . Subjects ≥ 40 ≤70 year age 4 . Metformin therapy oral antidiabetic medication allow 5 . Overweight obese ( BMI : 25 35 kg/m2 ) 6 . Normal liver kidney function 7 . Normal thyroid function 8 . Read understood informed consent form sign voluntarily 1 . Liver , heart , kidney , lung , infectious , neurological , psychiatric , immunological neoplastic disease . 2 . Type 1 insulin treat diabetes . 3 . Pregnancy lactation 4 . Illicit drug abuse alcoholism 5 . Subject treated insulin treatment degradationresistant GLP1R agonist ( Exendin4 ) similar DPP4 inhibitor ( Januvia ) 6 . Subjects take anoretic drug 7 . Subjects steroid treatment 8 . Subjects know principal investigator unable cooperate reason . 9 . Known hypersensitivity milk component 10 . Subjects bariatric surgery .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Whey protein</keyword>
	<keyword>type 2 diabetes</keyword>
</DOC>